Transmedics Group Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Transmedics Group Inc 公司

TransMedics Group, Inc. 是一家医疗技术公司，致力于为患有晚期肺、心和肝功能衰竭的患者提供器官移植疗法转型。该公司专门从事便携式体外温灌注和移植捐献器官评估。其器官护理系统 (OCS) 是一种便携式器官灌注、优化和监测系统，利用其定制技术在人体外复制捐献器官的近生理条件。该公司还开发了国家 OCS 计划 (NOP)，这是一个交钥匙解决方案，提供外包器官检索、OCS 器官管理和物流服务，以在美国开展移植计划。其物流服务包括航空运输、地面运输和其他协调活动。其 NOP 提供经过培训的器官采购外科医生、临床专家和移植协调员，利用其 OCS 技术提供端到端临床解决方案。

公司简介

公司代码TMDX

公司名称Transmedics Group Inc

上市日期May 02, 2019

成立日期2018

CEODr. Waleed H. Hassanein, M.D.

员工数量728

证券类型Ordinary Share

年结日May 02

公司地址200 Minuteman Road

城市ANDOVER

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编01810

电话19785520900

网址https://www.transmedics.com/

公司代码TMDX

上市日期May 02, 2019

成立日期2018

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Waleed H. Hassanein, M.D.

President, Chief Executive Officer, Director

481.61K

-8.98%

Mr. James R. Tobin

Independent Chairman of the Board

175.07K

-21.19%

Dr. David Weill, M.D.

Independent Director

10.73K

--

Mr. Nicholas (Nick) Corcoran

Senior Vice President - Supply Chain and Operations

7.04K

-44.49%

Ms. Merilee Raines, CPA

Independent Director

1.93K

--

Ms. Stephanie Lovell

Independent Director

1.93K

--

Mr. Thomas James Gunderson

Independent Director

1.93K

--

Mr. Anil Ranganath

Senior Vice President, General Counsel, Corporate Secretary

1.87K

-87.03%

Mr. Gerardo Hernandez

Chief Financial Officer, Treasurer

331.00

-97.93%

Mr. Edwin M. Kania, Jr.

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Dr. Waleed H. Hassanein, M.D.

President, Chief Executive Officer, Director

481.61K

-8.98%

Mr. James R. Tobin

Independent Chairman of the Board

175.07K

-21.19%

Dr. David Weill, M.D.

Independent Director

10.73K

--

Mr. Nicholas (Nick) Corcoran

Senior Vice President - Supply Chain and Operations

7.04K

-44.49%

Ms. Merilee Raines, CPA

Independent Director

1.93K

--

Ms. Stephanie Lovell

Independent Director

1.93K

--

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

OCS Liver net revenue

309.62M

70.83%

OCS Heart net revenue

109.86M

25.13%

OCS Lung net revenue

17.68M

4.04%

地区USD

名称

营收

占比

United States

421.88M

96.50%

All other countries

15.28M

3.50%

业务

地区

业务USD

名称

营收

占比

OCS Liver net revenue

309.62M

70.83%

OCS Heart net revenue

109.86M

25.13%

OCS Lung net revenue

17.68M

4.04%

股东统计

更新时间: 2月23日周日

持股股东

股东类型

持股股东

股东统计

占比

BlackRock Institutional Trust Company, N.A.

14.45%

Fidelity Management & Research Company LLC

11.68%

The Vanguard Group, Inc.

10.73%

State Street Global Advisors (US)

4.02%

Macquarie Investment Management

2.93%

Other

56.19%

持股股东

股东统计

占比

BlackRock Institutional Trust Company, N.A.

14.45%

Fidelity Management & Research Company LLC

11.68%

The Vanguard Group, Inc.

10.73%

State Street Global Advisors (US)

4.02%

Macquarie Investment Management

2.93%

Other

56.19%

股东类型

股东统计

占比

Investment Advisor

60.18%

Investment Advisor/Hedge Fund

38.06%

Hedge Fund

7.96%

Research Firm

3.62%

Individual Investor

2.99%

Bank and Trust

2.79%

Pension Fund

1.52%

Sovereign Wealth Fund

1.08%

Family Office

0.09%

机构持股

更新时间: 3月5日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q1

722

40.40M

120.00%

-704.37K

2024Q4

728

40.09M

119.11%

-642.74K

2024Q3

673

39.30M

117.10%

+1.37M

2024Q2

615

36.53M

110.85%

-3.27M

2024Q1

544

37.44M

113.97%

-4.28M

2023Q4

512

38.18M

116.94%

-3.46M

2023Q3

482

38.42M

117.77%

-240.92K

2023Q2

462

35.43M

108.88%

-81.81K

2023Q1

431

32.52M

99.99%

-2.56M

2022Q4

396

31.20M

98.07%

-3.79M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

4.89M

14.52%

+7.50K

+0.15%

Dec 31, 2024

Fidelity Management & Research Company LLC

3.95M

11.74%

+1.99M

+101.32%

Dec 31, 2024

The Vanguard Group, Inc.

3.63M

10.78%

+40.48K

+1.13%

Dec 31, 2024

State Street Global Advisors (US)

1.36M

4.04%

+88.13K

+6.92%

Dec 31, 2024

Macquarie Investment Management

992.50K

2.95%

+96.39K

+10.76%

Dec 31, 2024

UBS Asset Management Switzerland AG

973.96K

2.89%

+45.00K

+4.84%

Feb 28, 2025

Braidwell LP

922.10K

2.74%

+922.10K

--

Dec 31, 2024

UBS Asset Management (Switzerland)

866.16K

2.57%

+839.95K

+3.21K%

Dec 31, 2024

Fidelity International

855.36K

2.54%

+259.51K

+43.55%

Dec 31, 2024

Mackenzie Investments

828.15K

2.46%

+349.40K

+72.98%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

Clough Select Equity ETF

3.03%

Clough Hedged Equity ETF

2.66%

SPDR S&P Health Care Equipment ETF

1.53%

Invesco S&P SmallCap Health Care ETF

1.53%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.02%

Invesco S&P SmallCap 600 Pure Growth ETF

0.85%

BNY Mellon Innovators ETF

0.62%

Fidelity Sustainable US Equity ETF

0.57%

WisdomTree US SmallCap Quality Growth Fund

0.43%

SPDR S&P 600 Small Cap Growth ETF

0.33%

Clough Select Equity ETF

占比3.03%

Clough Hedged Equity ETF

占比2.66%

SPDR S&P Health Care Equipment ETF

占比1.53%

Invesco S&P SmallCap Health Care ETF

占比1.53%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比1.02%

Invesco S&P SmallCap 600 Pure Growth ETF

占比0.85%

BNY Mellon Innovators ETF

占比0.62%

Fidelity Sustainable US Equity ETF

占比0.57%

WisdomTree US SmallCap Quality Growth Fund

占比0.43%

SPDR S&P 600 Small Cap Growth ETF

占比0.33%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Transmedics Group Inc

92.430USD

Transmedics Group Inc

92.430

概览

公司